Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

LHC Capital's investment thesis on Pro Medicus Limited ($PME.AX) — Q2 2026 | Buyside Digest

All Pitches

View Letter Analysis

$PME.AXNASDAQPro Medicus Limited

BULL

LHC Capital—PME.AX

Fund Letter

Q2 2026

Published July 16, 2026

View Fund Profile

$163.92USD

-5.8% vs last month

$187.11Pitched

-12.4% since pitch

Market Cap$18.6B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Pro Medicus provides advanced medical imaging software, Visage, used by major hospitals and radiology networks to rapidly view, analyze, and manage complex clinical scans. LHC Capital maintains...

— Stephen Aboud, Marcus Hughes

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $PME.AX, and what else LHC Capital is buying.

Other pitches on $PME.AX

Other investors who've written on Pro Medicus Limited

Vision CapitalBULL

Pitched Apr 7, 2026

We updated our investment memo on Pro Medicus (ASX: PME) during the quarter.

View all $PME.AX pitches →